Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virus-Cell Interactions

A Mutant H3N2 Influenza Virus Uses an Alternative Activation Mechanism in TMPRSS2 Knockout Mice by Loss of an Oligosaccharide in the Hemagglutinin Stalk Region

Kouji Sakai, Tsuyoshi Sekizuka, Yasushi Ami, Noriko Nakajima, Minori Kitazawa, Yuko Sato, Katsuhiro Nakajima, Masaki Anraku, Toru Kubota, Katsuhiro Komase, Kazuaki Takehara, Hideki Hasegawa, Takato Odagiri, Masato Tashiro, Makoto Kuroda, Makoto Takeda
R. M. Sandri-Goldin, Editor
Kouji Sakai
aDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsuyoshi Sekizuka
bLaboratory of Bacterial Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasushi Ami
cDivision of Experimental Animal Research, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriko Nakajima
dDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Minori Kitazawa
aDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
eLaboratory of Animal Health, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuko Sato
dDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsuhiro Nakajima
aDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
eLaboratory of Animal Health, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masaki Anraku
aDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toru Kubota
aDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsuhiro Komase
aDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuaki Takehara
eLaboratory of Animal Health, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideki Hasegawa
dDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takato Odagiri
fInfluenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masato Tashiro
fInfluenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Makoto Kuroda
bLaboratory of Bacterial Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Makoto Takeda
aDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. M. Sandri-Goldin
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.00124-15
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The host protease TMPRSS2 plays an essential role in proteolytic activation of the influenza A virus (IAV) hemagglutinin (HA) protein possessing a monobasic cleavage site. However, after passages in TMPRSS2 knockout mice, an H3N2 subtype IAV began to undergo cleavage activation of HA, showing high virulence in the mice due to the loss of an oligosaccharide at position 8 in the HA stalk region. Thus, the H3N2 IAV acquired cleavability by an alternative HA activation mechanism/protease(s).

TEXT

Influenza A virus (IAV), a member of the Orthomyxoviridae family, affects and kills many humans worldwide. The viral hemagglutinin (HA) glycoprotein, which is responsible for receptor binding and subsequent membrane fusion, is synthesized as the inactive precursor, HA0, and cleaved by a host cell protease(s) into HA1 and HA2 subunits. The cleavage is essential for HA to mediate membrane fusion.

Using mouse models, three research groups recently demonstrated that a type II transmembrane serine protease, TMPRSS2, expressed in the airway epithelium, is critically important for HA cleavage in vivo (1–3). Mice lacking TMPRSS2 expression (TMPRSS2 knockout [tmprss2KO] mice) are highly tolerant of challenge infection by low-pathogenic (LP) IAVs possessing a monobasic cleavage site in HA. Our group (1) and Hatesuer et al. (2) showed that TMPRSS2 is essential for proteolytic activation of both H1N1 and H3N2 subtype IAVs. However, Tarnow et al. (3) reported that TMPRSS2 is not critical for activation of H3N2 IAV. Since the three groups used different H3N2 IAV strains, the discrepancy likely arose from possible variations in HA among the H3N2 IAV strains. The present study reveals a molecular determinant that modulates the TMPRSS2 dependency of H3N2 IAV in mouse lungs.

A mouse-adapted human H3N2 IAV strain, MA-A/Guizhou-X (H3WT) (1), was used as a reference wild-type (WT) virus. The virus was a reassortant H3N2 virus of A/Guizhou/54/89 (H3N2), a Chinese human isolate from 1989, and A/Puerto Rico/8/34 (H1N1) (4). The H3WT virus was passaged 10 times in tmprss2KO mice, and a tmprss2KO mouse-adapted MA-A/Guizhou-X virus (H3p10) was obtained.

The parental H3WT and H3p10 viruses were inoculated intranasally into tmprss2KO mice (n = 5). After challenge infection with 3.0 × 103 PFU of H3WT, tmprss2KO mice showed no body weight loss, while all TMPRSS2+/+ wild-type mice (tmprss2WT) showed severe body weight loss (Fig. 1A). Conversely, both tmprss2KO and tmprss2WT mice infected with 1.7 × 102 PFU of H3p10 showed severe body weight loss and required euthanasia on day 6 postinfection (p.i.) (Fig. 1B). To compare the susceptibility between the two mouse strains in detail, both mouse strains were also infected with 1.7 × 10, 1.7, and 0.17 PFU of H3p10 (Fig. 1C to E). The H3p10 infections exhibited pathogenicity in both tmprss2KO and tmprss2WT mice, although the pathological changes were slightly less severe in tmprss2KO mice than in tmprss2WT mice. The 50% lethal doses of H3p10 for tmprss2WT and tmprss2KO mice were 0.5 and 5.4 PFU, respectively. Histopathological examination revealed severe inflammation in the lungs of both tmprss2KO and tmprss2WT mice infected with H3p10, and viral antigens were detected throughout the lungs of both mouse strains (Fig. 1F).

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Pathogenicity of the parental (H3WT) and tmprss2KO mouse-adapted (H3p10) GZX[H3N2]. (A) Body weight kinetics of tmprss2WT (filled triangles) and tmprss2KO (open triangles) mice infected with 3.0 × 103 PFU of H3WT. (B to E) Body weight kinetics of tmprss2WT (filled triangles) and tmprss2KO (open triangles) mice infected with 1.7 × 102 (B), 1.7 × 10 (C), 1.7 (D), or 0.17 (E) PFU of H3p10. (F) Histopathological findings in the lungs of tmprss2WT and tmprss2KO mice infected with 1.7 × 102 PFU of H3p10. Data obtained by hematoxylin and eosin (HE) staining (original magnification, ×10) and immunohistochemistry (IHC) for the IAV nucleocapsid protein (original magnification, ×10) are shown.

Next, the extents of HA cleavage for H3p10 and H3WT in the infected lungs were compared between tmprss2WT and tmprss2KO mice (n = 3). On days 4 and 6 p.i., lung lavage fluids were obtained from the mice and subjected to SDS-PAGE and immunoblotting assays by using a rabbit antiserum against H3 (Fig. 2A, C, D) or a goat antiserum against whole H3N2 virions (Fig. 2B). Consistent with our previous observation in the lungs of tmprss2KO mice infected with H3WT, where HA remained in the uncleaved HA0 form (1), viral antigens were barely detectable by day 6 p.i., owing to the lack of multiple replication cycles (Fig. 2D). In contrast, H3p10 HA in the lungs of tmprss2KO mice was cleaved into the HA1 and HA2 subunits (Fig. 2A to C). However, the extents of cleavage estimated by the signal intensities of HA0 and the cleaved HA subunits (HA1 and HA2) were lower in tmprss2KO mice than in tmprss2WT mice (Fig. 2E).

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2

Proteolytic activation of H3p10 in tmprss2WT and tmprss2KO mice. (A to C) HA in lung lavage fluids from tmprss2WT and tmprss2KO mice infected with 1.7 × 102 PFU of H3p10 was analyzed by SDS-PAGE and immunoblotting. Data from days 4 (A) and 6 (C) p.i. using a rabbit antiserum against H3 and data from day 4 p.i. (B) using a goat antiserum against whole H3N2 virions are shown. Each lane corresponds to data from an individual mouse (n = 3). (D) HA proteins in lung lavage fluids from tmprss2WT and tmprss2KO mice infected with 3.0 × 103 PFU of H3WT were analyzed by SDS-PAGE and immunoblotting. Data on day 6 p.i. using a rabbit antiserum against H3 are shown. Each lane corresponds to data from an individual mouse (n = 3). (E) Quantification of cleavage by measuring the chemiluminescent signals for the immunoblots shown in panels A and C. The bar graph shows the ratios of cleaved HA subunit (HA1 and HA2) signals to total HA (HA1, HA2, and HA0) signals. Gray and black bars indicate data for cleavage in tmprss2WT and tmprss2KO mice, respectively. Data represent means ± standard deviations (SD). *, P < 0.01, significant difference based on a t test. (F) Virus titers in lung lavage fluids from tmprss2WT and tmprss2KO mice infected with 1.7 × 102 PFU of H3p10. Lung lavage fluids on days 2, 4, and 6 p.i. were untreated (Trypsin −) or treated with trypsin (Trypsin +) and used for virus titration. Data represent means ± SD. (G) Plaque formation of H3WT and H3p10 in MDCK cells in the presence or absence of trypsin.

The extent of infectivity activation of the progeny virus in the lungs was analyzed, as reported previously (1). Briefly, lung lavage fluids from tmprss2WT and tmprss2KO mice infected with 1.7 × 102 PFU of H3p10 on days 2, 4, and 6 p.i. were treated or untreated with trypsin in vitro, and the infectivity titers (PFU) were determined using MDCK cells. Our previous study demonstrated that H3WT replicated poorly and showed low virus titers in tmprss2KO mice (1). Only 1 to 2% of H3WT virus particles were activated in the lungs. In contrast, H3p10 replicated efficiently to high virus titers in the lungs of tmprss2KO mice. Although the mean virus titers were severalfold lower in tmprss2KO mice than in tmprss2WT mice, a statistical analysis showed no significant difference (Fig. 2F). The percentages of activated virus particles in tmprss2WT and tmprss2KO mice were 23.0 to 30.2% and 2.4 to 10.3%, respectively (Fig. 2F). To validate the assay, it was confirmed that H3p10 did not produce plaques in MDCK cells in the absence of trypsin (Fig. 2G).

The entire genome sequences of H3WT and H3p10 were analyzed by next-generation sequencing, as reported previously (5). Data for the RNA-seq reads of H3WT and H3p10 are available in the DDBJ Sequence Read Archive under accession number DRA002411. The data clearly demonstrated that the cytosine-to-adenine substitution at nucleotide position 86 in the HA gene was the most noticeable change throughout the viral genome between H3WT and H3p10 (Fig. 3; see also Fig. S1 to S8 in the supplemental material). This substitution was not detected (0.0%) in the H3WT genome, while 97.6% of the H3p10 genome possessed this substitution (Fig. 3; see also Fig. S4 in the supplemental material). The substitution was predicted to cause an asparagine-to-lysine substitution at amino acid position 8 (N8K [H3 numbering]) in the HA protein. As the asparagine residue constitutes a possible N-linked glycosylation motif [N-X-(S/T)] (6), this substitution was expected to cause loss of the oligosaccharide at the HA stalk. The predicted sites of oligosaccharide side chains in H3WT are shown on the structure of A/Aichi/2/1968 (PDB 5HMG) (Fig. 4). The oligosaccharide site at position 8 was located more distantly from the cleavage site, compared with positions 22 and 38 (Fig. 4). However, under physiological conditions, the relative location of the N-terminal region possessing an oligosaccharide at position 8 may be different.

FIG 3
  • Open in new tab
  • Download powerpoint
FIG 3

Acquisition of a single amino acid substitution in the HA protein of H3p10. (A, B) The read depths at nucleotide position 86 for H3WT and H3p10 were 44,124 and 914 reads, respectively. All 44,124 reads of the HA gene of H3WT show a cytosine at nucleotide position 86, whereas 892 reads of the HA gene of H3p10 show an adenine, and the remaining 22 reads show a cytosine at this position. An asparagine-to-lysine substitution at amino acid position 8 (N8K; H3 numbering) was predicted for this nonsynonymous substitution. The alignment was performed using BWA-SW software.

FIG 4
  • Open in new tab
  • Download powerpoint
FIG 4

Predicted positions of the oligosaccharides in H3WT. Based on the structure of A/Aichi/2/1968 (H3N2) (PDB 5HMG), the predicted positions of the oligosaccharide modifications in H3WT are shown. An HA molecule in a homotrimer is shown in blue. Circles with red dashed lines on the blue HA molecule indicate the predicted positions of oligosaccharide modifications. The N terminus of the HA protein and the cleavage site are indicated by red arrows.

No significant changes between H3WT and H3p10 were observed in the PB1, NP, NA, and M genome segments (see Fig. S2 and S5 to S7 in the supplemental material). On the other hand, the PB2, PA, and NS genome segments showed minor variations in the ratio of mixed nucleotides at several positions: 1091 and 1346 in PB2; 1893, 2014, and 2022 in PA; and 578 and 739 in NS (see Fig. S1, S3, and S8 in the supplemental material). For the PB2 and PA genes, the minor subpopulations found in H3WT became even less abundant in H3p10 (see Fig. S1 and S3 in the supplemental material). The reduction in minor variants in the PB2 and PA genes was very unlikely to account for the difference in HA cleavability. On the other hand, for the NS gene, the minor subpopulations found in H3WT were enriched in H3p10: 58.9% of the H3p10 NS2 protein and 22.3% of the H3WT NS2 protein were predicted to have a glycine-to-asparagine substitution at amino acid position 27 (G27N), and 28.8% of the H3p10 NS2 protein and only 0.9% of the H3WT NS2 protein were predicted to have a glutamine-to-lysine substitution at amino acid position 81 (Q81K) (see Fig. S8 in the supplemental material). Therefore, it was possible that the G27N and Q81K substitutions in the NS2 protein may partly contribute to the growth of H3p10 in mice, although it was unlikely that these changes in NS2 contributed to the cleavability of HA.

The loss of the oligosaccharide was confirmed by SDS-PAGE and immunoblotting assays. HA polypeptides of H3WT and H3p10 grown in MDCK cells in the presence of trypsin were analyzed. The molecular sizes of HA0 and HA1 of H3p10 were smaller than those of H3WT (Fig. 5A and B).

FIG 5
  • Open in new tab
  • Download powerpoint
FIG 5

Loss of an oligosaccharide at the stalk of HA of H3p10. (A, B) MDCK cells were infected with H3WT and H3p10, and the cells (A) and their culture supernatants (B) were subjected to SDS-PAGE and immunoblotting to detect HA.

Previous studies demonstrated that an H5 LP avian IAV acquired a highly pathogenic phenotype and trypsin-independent cleavability of HA by loss of the oligosaccharide at position 21 (H3 numbering) in the stalk region (7–10). The oligosaccharide, located in the vicinity of the cleavage site, likely prevented access of the multibasic cleavage site by ubiquitous host proteases. The hindrance could also be overcome by the addition of multiple basic amino acids to the cleavage site (11–13). A recent study showed a similar effect of the oligosaccharide on HA cleavage in an H9 LP avian IAV (14). The H9 HA contained an R-S-K-R cleavage motif, which was not cleavable by furin-like ubiquitous proteases when the oligosaccharide was present at the stalk region but became cleavable by these proteases when the oligosaccharide was removed (14).

Similar studies have been performed on human H3N2 IAV strains with a single arginine residue at the cleavage site (6, 15, 16). Ohuchi et al. (15) and Kawaoka (16) tested the effects of removing the oligosaccharide at position 22 (H3 numbering), located in the vicinity of the cleavage site (17, 18). Simple removal of the oligosaccharide did not render H3 HA cleavability in cultured cells. However, the oligosaccharide removal reduced the number of inserted arginine residues required to acquire trypsin-independent cleavability of the HA (15).

Rott et al. (6) reported that the HA of the human H3N2 X-31 strain acquired trypsin-independent cleavability in MDCK cells. The oligosaccharide loss at position 8 caused by the N8K substitution contributed to the increased cleavability in MDCK cells (6). The present study showed that although H3p10 had acquired the same N8K substitution as X-31, it failed to produce plaques in MDCK cells in the absence of trypsin (Fig. 2G). The difference in phenotypes between X-31 and H3p10 may be caused by heterogeneity within MDCK cells (19). While the oligosaccharide at position 22 (H3 numbering) is conserved among many HA subtypes, the sugar chain at position 8 is unique to the H3 subtype (20). The great majority of H3 IAV field isolates conserve the oligosaccharide at position 8, suggesting that most wild-type H3N2 viruses hold limited cleavability by TMPRSS2.

The present study demonstrated that H3WT was not activated proteolytically in tmprss2KO mouse lungs and that H3p10, which had lost the oligosaccharide side chain at HA position 8, underwent cleavage activation in tmprss2KO mouse lungs. H3p10 acquired the cleavability by an alternative HA activation mechanism/protease(s). It remains unclear whether the H3N2 strains used in other studies (2, 3) possessed the oligosaccharide at position 8. Since loss of the oligosaccharide could occur even in MDCK cells (6), the different passage histories of H3N2 viruses might result in different cleavability in vivo in the lungs. The differential cleavability of H3N2 viruses, possibly caused by loss of the sugar chain, may explain the discrepancy in the TMPRSS2 dependency of H3N2 IAV strains in previous studies (1–3).

In addition to TMPRSS2, many proteases, such as tryptase Clara (21), human airway trypsin-like protease (22), TMPRSS4 (23), TMPRSS13 (24), mosaic seine protease large-form (24), and matriptase (25, 26), have been shown to activate various IAV strains at different levels (27). Activation by these proteases may also be modulated by the oligosaccharide at position 8. It is of great interest to clarify the advantage for H3 IAV strains to conserve this oligosaccharide in nature.

ACKNOWLEDGMENTS

We thank all laboratory members of the Department of Virology 3, NIID, for technical support and valuable discussions. We also thank K. Maenaka for invaluable suggestions.

This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan and the Takeda Science Foundation.

FOOTNOTES

    • Received 16 January 2015.
    • Accepted 2 February 2015.
    • Accepted manuscript posted online 11 February 2015.
  • Supplemental material for this article may be found at http://dx.doi.org/10.1128/JVI.00124-15.

  • Copyright © 2015, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Sakai K,
    2. Ami Y,
    3. Tahara M,
    4. Kubota T,
    5. Anraku M,
    6. Abe M,
    7. Nakajima N,
    8. Sekizuka T,
    9. Shirato K,
    10. Suzaki Y,
    11. Ainai A,
    12. Nakatsu Y,
    13. Kanou K,
    14. Nakamura K,
    15. Suzuki T,
    16. Komase K,
    17. Nobusawa E,
    18. Maenaka K,
    19. Kuroda M,
    20. Hasegawa H,
    21. Kawaoka Y,
    22. Tashiro M,
    23. Takeda M
    . 2014. The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. J Virol 88:5608–5616. doi:10.1128/JVI.03677-13.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Hatesuer B,
    2. Bertram S,
    3. Mehnert N,
    4. Bahgat MM,
    5. Nelson PS,
    6. Pohlman S,
    7. Schughart K
    . 2013. Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice. PLoS Pathog 9:e1003774. doi:10.1371/journal.ppat.1003774.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Tarnow C,
    2. Engels G,
    3. Arendt A,
    4. Schwalm F,
    5. Sediri H,
    6. Preuss A,
    7. Nelson PS,
    8. Garten W,
    9. Klenk HD,
    10. Gabriel G,
    11. Bottcher-Friebertshauser E
    . 2014. TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice. J Virol 88:4744–4751. doi:10.1128/JVI.03799-13.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Tamura S,
    2. Ito Y,
    3. Asanuma H,
    4. Hirabayashi Y,
    5. Suzuki Y,
    6. Nagamine T,
    7. Aizawa C,
    8. Kurata T
    . 1992. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immunol 149:981–988.
    OpenUrlAbstract
  5. 5.↵
    1. Kuroda M,
    2. Katano H,
    3. Nakajima N,
    4. Tobiume M,
    5. Ainai A,
    6. Sekizuka T,
    7. Hasegawa H,
    8. Tashiro M,
    9. Sasaki Y,
    10. Arakawa Y,
    11. Hata S,
    12. Watanabe M,
    13. Sata T
    . 2010. Characterization of quasispecies of pandemic 2009 influenza A virus (A/H1N1/2009) by de novo sequencing using a next-generation DNA sequencer. PLoS One 5:e10256. doi:10.1371/journal.pone.0010256.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Rott R,
    2. Orlich M,
    3. Klenk HD,
    4. Wang ML,
    5. Skehel JJ,
    6. Wiley DC
    . 1984. Studies on the adaptation of influenza viruses to MDCK cells. EMBO J 3:3329–3332.
    OpenUrlPubMedWeb of Science
  7. 7.↵
    1. Kawaoka Y,
    2. Naeve CW,
    3. Webster RG
    . 1984. Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology 139:303–316. doi:10.1016/0042-6822(84)90376-3.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Kawaoka Y,
    2. Webster RG
    . 1985. Evolution of the A/Chicken/Pennsylvania/83 (H5N2) influenza virus. Virology 146:130–137. doi:10.1016/0042-6822(85)90059-5.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Webster RG,
    2. Kawaoka Y,
    3. Bean WJ Jr
    . 1986. Molecular changes in A/Chicken/Pennsylvania/83 (H5N2) influenza virus associated with acquisition of virulence. Virology 149:165–173. doi:10.1016/0042-6822(86)90118-2.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Deshpande KL,
    2. Fried VA,
    3. Ando M,
    4. Webster RG
    . 1987. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc Natl Acad Sci U S A 84:36–40. doi:10.1073/pnas.84.1.36.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Kawaoka Y,
    2. Webster RG
    . 1989. Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin. J Virol 63:3296–3300.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Kawaoka Y,
    2. Webster RG
    . 1988. Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci U S A 85:324–328. doi:10.1073/pnas.85.2.324.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Ohuchi M,
    2. Orlich M,
    3. Ohuchi R,
    4. Simpson BE,
    5. Garten W,
    6. Klenk HD,
    7. Rott R
    . 1989. Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2). Virology 168:274–280. doi:10.1016/0042-6822(89)90267-5.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Tse LV,
    2. Hamilton AM,
    3. Friling T,
    4. Whittaker GR
    . 2014. A novel activation mechanism of avian influenza virus H9N2 by furin. J Virol 88:1673–1683. doi:10.1128/JVI.02648-13.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Ohuchi R,
    2. Ohuchi M,
    3. Garten W,
    4. Klenk HD
    . 1991. Human influenza virus hemagglutinin with high sensitivity to proteolytic activation. J Virol 65:3530–3537.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Kawaoka Y
    . 1991. Structural features influencing hemagglutinin cleavability in a human influenza A virus. J Virol 65:1195–1201.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Chen J,
    2. Lee KH,
    3. Steinhauer DA,
    4. Stevens DJ,
    5. Skehel JJ,
    6. Wiley DC
    . 1998. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95:409–417. doi:10.1016/S0092-8674(00)81771-7.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Steinhauer DA
    . 1999. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1–20. doi:10.1006/viro.1999.9716.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Lugovtsev VY,
    2. Melnyk D,
    3. Weir JP
    . 2013. Heterogeneity of the MDCK cell line and its applicability for influenza virus research. PLoS One 8:e75014. doi:10.1371/journal.pone.0075014.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Nobusawa E,
    2. Aoyama T,
    3. Kato H,
    4. Suzuki Y,
    5. Tateno Y,
    6. Nakajima K
    . 1991. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182:475–485. doi:10.1016/0042-6822(91)90588-3.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Kido H,
    2. Yokogoshi Y,
    3. Sakai K,
    4. Tashiro M,
    5. Kishino Y,
    6. Fukutomi A,
    7. Katunuma N
    . 1992. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem 267:13573–13579.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Bottcher E,
    2. Matrosovich T,
    3. Beyerle M,
    4. Klenk HD,
    5. Garten W,
    6. Matrosovich M
    . 2006. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 80:9896–9898. doi:10.1128/JVI.01118-06.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Chaipan C,
    2. Kobasa D,
    3. Bertram S,
    4. Glowacka I,
    5. Steffen I,
    6. Tsegaye TS,
    7. Takeda M,
    8. Bugge TH,
    9. Kim S,
    10. Park Y,
    11. Marzi A,
    12. Pohlmann S
    . 2009. Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol 83:3200–3211. doi:10.1128/JVI.02205-08.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Okumura Y,
    2. Takahashi E,
    3. Yano M,
    4. Ohuchi M,
    5. Daidoji T,
    6. Nakaya T,
    7. Bottcher E,
    8. Garten W,
    9. Klenk HD,
    10. Kido H
    . 2010. Novel type II transmembrane serine proteases, MSPL and TMPRSS13, proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication. J Virol 84:5089–5096. doi:10.1128/JVI.02605-09.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Beaulieu A,
    2. Gravel E,
    3. Cloutier A,
    4. Marois I,
    5. Colombo E,
    6. Desilets A,
    7. Verreault C,
    8. Leduc R,
    9. Marsault E,
    10. Richter MV
    . 2013. Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium. J Virol 87:4237–4251. doi:10.1128/JVI.03005-12.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Hamilton BS,
    2. Gludish DW,
    3. Whittaker GR
    . 2012. Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities. J Virol 86:10579–10586. doi:10.1128/JVI.00306-12.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Galloway SE,
    2. Reed ML,
    3. Russell CJ,
    4. Steinhauer DA
    . 2013. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog 9:e1003151. doi:10.1371/journal.ppat.1003151.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
A Mutant H3N2 Influenza Virus Uses an Alternative Activation Mechanism in TMPRSS2 Knockout Mice by Loss of an Oligosaccharide in the Hemagglutinin Stalk Region
Kouji Sakai, Tsuyoshi Sekizuka, Yasushi Ami, Noriko Nakajima, Minori Kitazawa, Yuko Sato, Katsuhiro Nakajima, Masaki Anraku, Toru Kubota, Katsuhiro Komase, Kazuaki Takehara, Hideki Hasegawa, Takato Odagiri, Masato Tashiro, Makoto Kuroda, Makoto Takeda
Journal of Virology Apr 2015, 89 (9) 5154-5158; DOI: 10.1128/JVI.00124-15

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Mutant H3N2 Influenza Virus Uses an Alternative Activation Mechanism in TMPRSS2 Knockout Mice by Loss of an Oligosaccharide in the Hemagglutinin Stalk Region
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Mutant H3N2 Influenza Virus Uses an Alternative Activation Mechanism in TMPRSS2 Knockout Mice by Loss of an Oligosaccharide in the Hemagglutinin Stalk Region
Kouji Sakai, Tsuyoshi Sekizuka, Yasushi Ami, Noriko Nakajima, Minori Kitazawa, Yuko Sato, Katsuhiro Nakajima, Masaki Anraku, Toru Kubota, Katsuhiro Komase, Kazuaki Takehara, Hideki Hasegawa, Takato Odagiri, Masato Tashiro, Makoto Kuroda, Makoto Takeda
Journal of Virology Apr 2015, 89 (9) 5154-5158; DOI: 10.1128/JVI.00124-15
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514